Delivery Order SPE2D021DA002-SPE2D326F1157

The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $2,919.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vials. This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award was issued under DMS Pharmaceutical Group's recently established Indefinite Delivery Contract (IDC) designated SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Defense Department acquisition strategy designed to meet recurring pharmaceutical supply needs across military healthcare facilities worldwide.

DMS Pharmaceutical Group's selection as a prime vendor contractor under PPV-G GEN V demonstrates the company's established performance and capability to supply a comprehensive range of pharmaceutical products to Department of Defense operations. The vendor's product portfolio spans branded and generic prescription medications, biologics, vaccines, and medical consumables, positioning it as a critical component of the federal pharmaceutical supply chain. With the parent IDC featuring a $499.99 billion ceiling value and extending through December 31, 2036, this delivery order for YF-VAX represents one of numerous orders the contractor is authorized to fulfill in support of DoD healthcare operations.